Having trouble accessing articles? Reset your cache.

P280-technetium-99m targeting platelet receptor GPIIb/IIIa data

DITI announced that several studies presented at the meeting of the Society of Nuclear Medicine in San Antonio, Texas, showed the accuracy of the imaging agent. An NDA will be submitted this year.

In one trial in 39 patients,

Read the full 392 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers